Waiting For The Perfect Case: Why EMA Has Yet To Hold A Public Drug Safety Hearing

The European Medicines Agency has yet to use the power it has to hold public hearings on marketed medicines that raise safety concerns. It says it will do so only when the time is right.

More from Drug Safety

More from Pink Sheet